Latour, Jos M.
Kentish-Barnes, Nancy
Jacques, Theresa
Wysocki, Marc
Azoulay, Elie
Metaxa, Victoria
Funding for this research was provided by:
GE Healthcare
Article History
Received: 24 June 2022
Accepted: 5 July 2022
First Online: 18 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: The financial competing interest are: JML, NKB; TJ, EA and VM received a fee for presenting or chairing at the GE Healthcare sponsored session at the LIVES2021 congress. MW is a representative of GE Healthcare, and this commercial company sponsored the industry-sponsored session at the LIVES2021 congress. GE Healthcare adhered to the Good Publication Practice guidelines for pharmaceutical companies. In addition, EA has received fees for lectures from Gilead, Pfizer, Sanofi, and Alexion. His research group has been supported by Baxter, Fisher & Payckle, Jazz Pharma, and MSD. VM has received lecturing fees from Gilead. The non-financial competing interests are: All authors declare that the content of the manuscript reflect their own view and not of any organisation.